Mitochondrial diseases

Anesthesia and Uncommon Diseases

Volumn , Issue , 2006, Pages 455-467

  Levy, Richard J ^a   Muravchick, Stanley ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77953744569     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-141602212-1.50017-2     Document Type: Chapter

References (77)

1. Linnane AW, Marzuki S, Ozawa T, et al. Mitochondrial DNA mutations as an important contributor to ageing and degenerative diseases. Lancet 1989, 1:642-651.
2. Hattori K, Tanaka M, Sugiyama S, et al. Age-dependent decrease in mitochondrial DNA in the human heart: Possible contributory factor to presbycardia. Am Heart J 1991, 121:1735-1742.
3. Wallace DC Mitochondrial diseases in man and mouse. Science 1999, 283:1482-1488.
4. DiMauro S, Schon EA Mitochondrial respiratory-chain diseases. N Engl J Med 2003, 348:2656-2668.
5. Wei YH Mitochondrial DNA mutations and oxidative damage in aging and diseases: An emerging paradigm of gerontology and medicine. Proc Natl Sci Council (China) Part B 1998, 22:55-67.
6. Schmiedel J, Jackson S, Schafer J, et al. Mitochondrial cytopathies. J Neurol 2003, 250:267-277.
7. Schwartz M, Vissing J New patterns of inheritance in mitochondrial disease. Biochem Biophys Res Comm 2003, 310:247-251.
8. Kagawa Y, Hamamoto T, Endo H, et al. Genes of human ATP synthase: Their roles in physiology and aging. Biosci Report 1997, 17:115-146.
9. Cohen PJ Effect of anesthetics on mitochondrial function. Anesthesiology 1973, 39:153-164.
10. Nahrwold ML, Clark CR, Cohen PJ Is depression of mitochondrial respiration a predictor of in-vivo anesthetic activity?. Anesthesiology 1974, 40:566-570.
11. Lee SL, Alto LE, Dhalla NS Subcellular effects of some anesthetic agents on rat myocardium. Can J Physiol Pharmacol 1979, 57:65-71.
12. Hanley PJ, Ray J, Brandt U, et al. Halothane, isoflurane and sevoflurane inhibit NADH:ubiquinone oxidoreductase (complex I) of cardiac mitochondria. J Physiol 2002, 544:687-693.
13. Nahrwold ML, Cohen PJ Additive effect of nitrous oxide and halothane on mitochondrial function. Anesthesiology 1973, 39:534-536.
14. Garlid KD, Nakashima RA Studies on the mechanism of uncoupling by amine local anesthetics: Evidence for mitochondrial proton transport mediated by lipophilic ion pairs. J Biol Chem 1983, 258:7974-7980.
15. Tarba C, Cracium C A comparative study of the effects of procaine, lidocaine, tetracaine, and dibucaine on the functions and ultrastructure of isolated rat liver mitochondria. Biochem Biophys Acta 1990, 1019:19-28.
16. Stevanato R, Momo F, Marian M, et al. Effects of nitrosopropofol on mitochondrial energy-converting system. Biochem Pharmacol 2002, 64:1133-1138.
17. Schenkman KA, Yan S Propofol impairment of mitochondrial respiration in isolated perfused guinea pig hearts determined by reflectance spectroscopy. Crit Care Med 2000, 28:172-177.
18. Rigoulet M, Devin A, Averet N, et al. Mechanisms of inhibition and uncoupling of respiration in isolated rat liver mitochondria by the general anesthetic 2,6-diisopropylphenol. Eur J Biochem 1996, 241:280-285.
19. Raeburn CD, Cleveland JC, Zimmerman MA, et al. Organ preconditioning. Arch Surg 2001, 136:1263-1266.
20. Treem WR, Sokol RJ Disorders of the mitochondria. Semin Liver Dis 1998, 18:237-253.
21. Suomalainen A, Kaukonen J Diseases caused by nuclear genes affecting mtDNA stability. Am J Med Genet 2001, 106:53-61.
22. Tatuch Y, Robinson BH The mitochondrial DNA mutation at 8993 associated with NARP slows the rate of ATP synthesis in isolated lymphoblast mitochondria. Biochem Biophys Res Comm 1993, 192:124-128.
23. Minamoto H, Kawabata K, Okuda B, et al. Mitochondrial encephalomyopathy with elderly onset of stroke-like episodes. Intern Med 1996, 35:991-995.
24. Wallace DC, Lott MT, Shoffner JM, et al. Diseases resulting from mitochondrial DNA point mutations. J Inherit Metabol Dis 1992, 15:472-479.
25. Beal MF Mitochondria, oxidative damage, and inflammation in Parkinson's disease. Ann NY Acad Sci 2003, 991:120-131.
26. Jordan J, Cena V, Prehn JH Mitochondrial control of neuron death and its role in neurodegenerative disorders. J Physiol Biochem 2003, 59:129-141.
27. Kalman B, Leist TP A mitochondrial component of neurodegeneration in multiple sclerosis. Neurol Mol Med 2003, 3:147-158.
28. Stolzing A, Grune T The proteasome and its function in the ageing process. Clin Exp Dermatol 2001, 26:566-572.
29. Gillis LA, Sokol RJ Gastrointestinal manifestations of mitochondrial disease. Gastroenterol Clin North Am 2003, 32:789-817.
30. Eng C, Kiuru M, Fernandez MJ, et al. A role for mitochondrial enzymes in inherited neoplasia and beyond. Nat Rev Cancer 2003, 3:193-202.
31. Rotig A Renal disease and mitochondrial genetics. J Nephrol 2003, 16:286-292.
32. Pipinos II, Sharov VG, Shepard AD, et al. Abnormal mitochondrial respiration in skeletal muscle in patients with peripheral arterial disease. J Vasc Surg 2003, 38:827-832.
33. Yorek MA The role of oxidative stress in diabetic vascular and neural disease. Free Radical Res 2003, 37:471-480.
34. Petersen KF, Befroy D, Dufour S, et al. Mitochondrial dysfunction in the elderly: Possible role in insulin resistance. Science 2003, 300:1140-1142.
35. Petersen KF, Dufour S, Befroy D, et al. Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. N Engl J Med 2004, 350:664-671.
36. Monteiro P, Oliveira PJ, Concalves L, et al. Pharmacological modulation of mitochondrial function during ischemia and reperfusion. Rev Port Cardiol 2003, 22:407-429.
37. Corral-Debrinski M, Stepien G, Shoffner M, et al. Hypoxemia is associated with mitochondrial DNA damage and gene induction: Implications for cardiac disease. JAMA 1991, 266:1812-1816.
38. Byrne JA, Grieve DJ, Cave AC, et al. Oxidative stress and heart failure. Arch Mal Coeur Vaisseaux 2003, 96:214-221.
39. Davies MG, Hagen PO Systemic inflammatory response syndrome. Br J Surg 1997, 84:920-935.
40. 2 sensor. J Biol Chem 1998, 273:3320-3326.
41. Fink MP Bench-to-bedside review: Cytopathic hypoxia. Crit Care 2002, 6:491-499.
42. Bruemmer-Smith S, Stuber F, Schroeder S Protective functions of intracellular heat-shock protein (HSP) 70-expression in patients with severe sepsis. Intens Care Med 2001, 27:1835-1841.
43. Watts JA, Kline JA, Thornton LR, et al. Metabolic dysfunction and depletion of mitochondria in hearts of septic rats. J Mol Cell Cardiol 2004, 36:141-150.
44. Gellerich FN, Trumbeckaite S, Hertel K, et al. Impaired energy metabolism in hearts of septic baboons: Diminished activities of complex I and complex II of the mitochondrial respiratory chain. Shock 1999, 11:336-341.
45. Levy RJ, Vijayasarathy C, Raj NR, et al. Competitive and noncompetitive inhibition of myocardial cytochrome C oxidase in sepsis. Shock 2004, 21:110-114.
46. Brunori M, Giuffre A, Sarti P, et al. Nitric oxide and cellular respiration. Cell Mol Life Sci 1999, 56:549-557.
47. Sharpe MA, Cooper CE Interaction of peroxynitrite with mitochondrial cytochrome oxidase: Catalytic production of nitric oxide and irreversible inhibition of enzyme activity. J Biol Chem 1998, 273:30961-30972.
48. Luft R The development of mitochondrial medicine. Proc Natl Acad Sci U S A 1994, 91:8731-8738.
49. Barja G, Herrero A Oxidative damage to mitochondrial DNA is inversely related to maximum life span in the heart and brain of mammals. FASEB J 2000, 14:312-318.
50. Sohal RS, Weindruch R Oxidative stress, caloric restriction, and aging. Science 1996, 273:59-63.
51. Stadtman ER Protein oxidation in aging and age-related diseases. Ann NY Acad Sci 2001, 928:22-38.
52. Ozawa T Genetic and functional changes in mitochondria associated with aging. Physiol Rev 1997, 77:425-464.
53. Hattori K, Tanaka M, Sugiyama S, et al. Age-dependent decrease in mitochondrial DNA in the human heart: Possible contributory factor to presbycardia. Am Heart J 1991, 121:1735-1742.
54. Knight JA The biochemistry of aging. Adv Clin Chem 2000, 35:1-62.
55. Ravagnan L, Roumier T, Kroemer G Mitochondria, the killer organelles and their weapons. J Cell Physiol 2002, 192:131-137.
56. Chen HW, Hsu C, Lu TS, et al. Heat shock pretreatment prevents cardiac mitochondrial dysfunction during sepsis. Shock 2003, 20:274-279.
57. Sheth K, De A, Nolan B, et al. Heat shock protein 27 inhibits apoptosis in human neutrophils. J Surg Res 2001, 99:129-133.
58. Griggs RC, Karpati G Muscle pain, fatigue, and mitochondriopathies. N Engl J Med 1999, 341:1077-1078.
59. Walker UA, Collins S, Byrne E Respiratory chain encephalomyopathies: A diagnostic classification. Eur Neurol 1996, 36:260-267.
60. Cohen BH Mitochondrial cytopathies: A primer. Mitochondrial cytopathies 2000, http://www.umdf.org/pdf/MITOCYTO.PDF.
61. Grattan-Smith PJ, Shield LK, Hopkins IJ, et al. Acute respiratory failure precipitated by general anesthesia in Leigh's syndrome. J Child Neurol 1990, 5:137-141.
62. Lauwers MR, Van Lersberghe C, Camu F Inhalation anaesthesia and the Kearns-Sayre syndrome. Anaesthesia 1994, 49:876-878.
63. Maslow A, Lisbon A Anesthetic considerations in patients with mitochondrial dysfunction. Anesth Analg 1993, 76:884-886.
64. Matsuno S, Hashimoto H, Matsuki A Neuroleptanesthesia for a patient with mitochondrial encephalomyopathy. Masui 1994, 43:1038-1040. In Japanese.
65. Wiesel S, Bevan JC, Samuel J, et al. Vecuronium neuromuscular blockade in a child with mitochondrial myopathy. Anesth Analg 1991, 72:696-699.
66. D'Ambra MN, Dedrick D, Savarese JJ Kearns-Sayre syndrome and pancuronium-succiny1choline induced neuromuscular blockade. Anesthesiology 1979, 51:343-345.
67. Naguib M, el Dawlatly AA, Ashour M, et al. Sensitivity to mivacurium in a patient with mitochondrial myopathy. Anesthesiology 1996, 84:1506-1509.
68. Itaya K, Takahata O, Mamiya K, et al. Anesthetic management of two patients with mitochondrial encephalopathy, lactic acidosis and stroke-like episodes (MELAS). Masui 1995, 44:710-712. In Japanese.
69. Figarella-Branger D, Kozak-Ribbens G, Rodet L, et al. Pathological findings in 165 patients explored for malignant hyperthermia susceptibility. Neuromusc Dis 1993, 3:553-556.
70. Johnston W, Karpati G, Carpenter S, et al. Late-onset mitochondrial myopathy. Ann Neurol 1995, 37:16-23.
71. Sabate S, Ferrandiz M, Paniagua P, et al. Anesthesia in Kearns-Sayre syndrome mitochondrial myopathy. Rev Esp Anestesiol Reanimacion 1996, 43:255-257. In Spanish.
72. Ciccotelli KK, Prak EL, Muravchick S An adult with inherited mitochondrial encephalomyopathy: Report of a case. Anesthesiology 1997, 87:1240-1242.
73. Tanaka K, Ludwig LM, Kersten JR, et al. Mechanisms of cardioprotection by volatile anesthetics. Anesthesiology 2004, 100:707-721.
74. Lennmarken C, Lindholm M-L, Greenwald S, et al. Confirmation that low intraoperative BIS™ levels predict increased risk of post-operative mortality. Anesthesiology 2003, 99:A303.
75. Weldon BC, Mahla ME, van der Aa MT, et al. Advancing age and deeper intraoperative anesthetic levels are associated with higher first year death rates. Anesthesiology 2002, 96:A1097.
76. Kayser EB, Morgan PG, Sedensky MM GAS-1: A mitochondrial protein controls sensitivity to volatile anesthetics in the nematode Caenorhabditis elegans. Anesthesiology 1999, 90:545-554.
77. Morgan PG, Hoppel CL, Sedensky MM Mitochondrial defects and anesthetic sensitivity. Anesthesiology 2002, 96:1268-1270.